PipelineReview.com11 小时
CARsgen’s Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in a Patient with ...
SHANGHAI, China I7, 2025 I CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for ...
PipelineReview.com11 小时
Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for ...
DONGGUAN, China I February 28, 2025 I Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce ...